Jun 17 |
Spotlight on Eli Lilly and Co: Analyzing the Surge in Options Activity
|
Jun 17 |
The Zacks Analyst Blog Highlights Berkshire Hathaway, Eli Lilly, PepsiCo, Hovnanian and IDT
|
Jun 17 |
Two Is Better Than One in the Alzheimer’s Market
|
Jun 17 |
Lilly’s Phase II results in Alzheimer’s disease have most experts saying donanemab is done
|
Jun 16 |
Ozempic drives more demand for smaller clothes, WSJ reports
|
Jun 16 |
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
|
Jun 15 |
Mounjaro Is Targeting Another Multibillion-Dollar Market: Is Eli Lilly Stock a Buy?
|
Jun 15 |
U.S. drug shortages worsen to reach a decade high: report
|
Jun 15 |
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster
|
Jun 15 |
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
|